^

Provider Resources

Section Menu  

 

Authorized User (AU) Training Program for Radiopharmaceutical Therapy

Section 1: Applicant Information

Primary Specialty:

Section 2: Radiation Safety and Licensing Information

Section 3: Eligibility and Background

1. Are you currently an Authorized User (AU) for oral administration of sodium iodide I-131?

2. Are you currently pursuing AU status for the parenteral administration of a radioactive drug, for example Lu-177?

3. Have you completed all required training hours, based on NRC or Agreement State requirements for AU Status for parenteral administration of radiopharmaceuticals?

Describe your current experience with radiopharmaceuticals or systemic radiation therapy:

Section 2: Host Facility Placement

Section 4: Required Supporting Documents (attach with submission)

Section 5: Pre-Learning Requirements

Section 6: Host Facility Placement

Section 7: Certification and Acknowledgment

By signing below, I confirm that all information provided is accurate and complete. I understand that participation in the AU Training Program does not, by itself, confer Authorized User status for radiopharmaceuticals, and that final authorization is granted only by the NRC or my Agreement State upon review of all required documentation.

Section 8: RSO Confirmation

Section 9: Agreement State/NRC Confirmation (attach letter or complete below)

Copyright © 2025 American Society for Radiation Oncology